Keyvan Pedrood

430 total citations
18 papers, 340 citations indexed

About

Keyvan Pedrood is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Keyvan Pedrood has authored 18 papers receiving a total of 340 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Organic Chemistry, 7 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Keyvan Pedrood's work include Synthesis and biological activity (5 papers), Chemical Synthesis and Analysis (4 papers) and Synthesis and Characterization of Heterocyclic Compounds (4 papers). Keyvan Pedrood is often cited by papers focused on Synthesis and biological activity (5 papers), Chemical Synthesis and Analysis (4 papers) and Synthesis and Characterization of Heterocyclic Compounds (4 papers). Keyvan Pedrood collaborates with scholars based in Iran and Türkiye. Keyvan Pedrood's co-authors include Bagher Larijani, Mohammad Mahdavi, Mohammad Mahdavi, Maryam Mohammadi‐Khanaposhtani, Hossein Rastegar, Mohammad Nazari Montazer, Samanesadat Hosseini, Mohammad Asgari, Mina Saeedi and Sussan K. Ardestani and has published in prestigious journals such as Scientific Reports, Tetrahedron and International Journal of Biological Macromolecules.

In The Last Decade

Keyvan Pedrood

17 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keyvan Pedrood Iran 12 258 125 48 35 30 18 340
Ali Moazzam Iran 13 247 1.0× 95 0.8× 20 0.4× 48 1.4× 32 1.1× 39 370
Farman Ali Pakistan 11 307 1.2× 126 1.0× 62 1.3× 93 2.7× 55 1.8× 24 453
Muhammad Fakhri Indonesia 10 206 0.8× 93 0.7× 32 0.7× 76 2.2× 31 1.0× 35 380
Shahbaz Shamim Pakistan 10 319 1.2× 96 0.8× 32 0.7× 98 2.8× 48 1.6× 20 400
Şule Ceylan Türkiye 11 219 0.8× 111 0.9× 36 0.8× 8 0.2× 25 0.8× 36 359
Mehwish Solangi Pakistan 6 214 0.8× 62 0.5× 46 1.0× 61 1.7× 44 1.5× 17 286
Faryal Chaudhry Pakistan 11 302 1.2× 73 0.6× 46 1.0× 98 2.8× 45 1.5× 29 368
Naveed Iqbal Pakistan 11 136 0.5× 86 0.7× 66 1.4× 65 1.9× 38 1.3× 19 303
Shabnam Mahernia Iran 12 264 1.0× 140 1.1× 35 0.7× 59 1.7× 28 0.9× 27 471
Zainab Zainab Pakistan 13 383 1.5× 101 0.8× 57 1.2× 78 2.2× 108 3.6× 51 555

Countries citing papers authored by Keyvan Pedrood

Since Specialization
Citations

This map shows the geographic impact of Keyvan Pedrood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keyvan Pedrood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keyvan Pedrood more than expected).

Fields of papers citing papers by Keyvan Pedrood

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keyvan Pedrood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keyvan Pedrood. The network helps show where Keyvan Pedrood may publish in the future.

Co-authorship network of co-authors of Keyvan Pedrood

This figure shows the co-authorship network connecting the top 25 collaborators of Keyvan Pedrood. A scholar is included among the top collaborators of Keyvan Pedrood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keyvan Pedrood. Keyvan Pedrood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Pedrood, Keyvan, Ali Moazzam, Aida Iraji, et al.. (2023). Design, synthesis, and cytotoxic evaluation of quinazoline derivatives bearing triazole-acetamides. Heliyon. 9(2). e13528–e13528. 12 indexed citations
3.
Azizian, Homa, Keyvan Pedrood, Ali Moazzam, et al.. (2022). Docking study, molecular dynamic, synthesis, anti-α-glucosidase assessment, and ADMET prediction of new benzimidazole-Schiff base derivatives. Scientific Reports. 12(1). 14870–14870. 29 indexed citations
4.
Iraji, Aida, Ali Moazzam, Meysam Soleimani, et al.. (2022). Synthesis, molecular docking, and cytotoxicity of quinazolinone and dihydroquinazolinone derivatives as cytotoxic agents. BMC Chemistry. 16(1). 35–35. 7 indexed citations
5.
Ansari, Samira, Milad Noori, Keyvan Pedrood, et al.. (2022). Novel aryl(4-phenylpiperazin-1-yl)methanethione derivatives as new anti-Alzheimer agents: Design, synthesis, in vitro and in silico assays. Journal of Molecular Structure. 1262. 132945–132945. 6 indexed citations
6.
Hajimiri, Mirhamed, Mehdi Khoshneviszadeh, Keyvan Pedrood, et al.. (2022). Rational Design, Synthesis, in Vitro, and in Silico Studies of Chlorophenylquinazolin‐4(3H)‐One Containing Different Aryl Acetohydrazides as Tyrosinase Inhibitors. Chemistry & Biodiversity. 19(7). e202100964–e202100964. 11 indexed citations
7.
Pedrood, Keyvan, Homa Azizian, Mohammad Nazari Montazer, et al.. (2022). Design and synthesis of new N-thioacylated ciprofloxacin derivatives as urease inhibitors with potential antibacterial activity. Scientific Reports. 12(1). 13827–13827. 19 indexed citations
8.
Pedrood, Keyvan, et al.. (2022). Synthesis of heterocycles by utilizing phthalaldehydic acid: An overview. Tetrahedron. 127. 133073–133073.
9.
Pedrood, Keyvan, Zahra Rezaei, Bagher Larijani, et al.. (2022). Design, synthesis, and molecular docking studies of diphenylquinoxaline-6-carbohydrazide hybrids as potent α-glucosidase inhibitors. BMC Chemistry. 16(1). 678–681. 10 indexed citations
10.
Pedrood, Keyvan, et al.. (2021). Catalytic and non-catalytic amidation of carboxylic acid substrates. Molecular Diversity. 26(2). 1311–1344. 17 indexed citations
11.
Pedrood, Keyvan, Homa Azizian, Mohammad Nazari Montazer, et al.. (2021). Arylmethylene hydrazine derivatives containing 1,3-dimethylbarbituric moiety as novel urease inhibitors. Scientific Reports. 11(1). 10607–10607. 22 indexed citations
12.
Ansari, Samira, Homa Azizian, Keyvan Pedrood, et al.. (2021). Design, synthesis, and α‐glucosidase‐inhibitory activity of phenoxy‐biscoumarin–N‐phenylacetamide hybrids. Archiv der Pharmazie. 354(12). e2100179–e2100179. 16 indexed citations
13.
Asgari, Mohammad, Ebrahim Barzegari, Keyvan Pedrood, et al.. (2021). New quinoxalin‐1,3,4‐oxadiazole derivatives: Synthesis, characterization, in vitro biological evaluations, and molecular modeling studies. Archiv der Pharmazie. 354(9). e2000471–e2000471. 17 indexed citations
14.
Mahdavi, Mohammad, Keyvan Pedrood, Mohammad Nazari Montazer, & Bagher Larijani. (2021). Recent Advances in the Synthesis of Heterocycles by the Aza-Wittig Reaction. Synthesis. 53(14). 2342–2366. 23 indexed citations
15.
Pedrood, Keyvan, et al.. (2021). Synthesis of Chromene-Fused Heterocycles by the Intramolecular–Diels–Alder Reaction: An Overview. Tetrahedron. 102. 132524–132524. 8 indexed citations
16.
Pedrood, Keyvan, Maryam Mohammadi‐Khanaposhtani, Mohammad Asgari, et al.. (2020). Design, synthesis, characterization, enzymatic inhibition evaluations, and docking study of novel quinazolinone derivatives. International Journal of Biological Macromolecules. 170. 1–12. 49 indexed citations
17.
Iranpoor, Nasser, et al.. (2016). Regioselective hydrocarbonylation of phenylacetylene to α,β-unsaturated esters and thioesters with Fe(CO)5 and Mo(CO)6. Journal of Organometallic Chemistry. 822. 67–73. 23 indexed citations
18.
Mahdavi, Mohammad, Keyvan Pedrood, Maliheh Safavi, et al.. (2015). Synthesis and anticancer activity of N-substituted 2-arylquinazolinones bearing trans-stilbene scaffold. European Journal of Medicinal Chemistry. 95. 492–499. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026